Sharekhan

Narayana Hrudayalaya Ltd

Wed 30/04/2025,15:51:37 | NSE : NH

₹ 1760.50-15.30 (-0.86%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1765.80

Previous Close

₹ 1775.80

Volume

314492

Mkt Cap ( Rs. Cr)

₹35977.72

High

₹ 1800.00

Low

₹ 1744.60

52 Week High

₹ 1871.60

52 Week Low

₹ 1080.00

Book Value Per Share

₹ 156.86

Dividend Yield

0.22

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Narayana Hrudayalaya Ltd

Your Vote -

Buy

77.78%

Hold

11.11%

Sell

11.11%

77.78%

18 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1760.50

25

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

25

Option Chain

Analyzes market sentiment, predicts Narayana Hrudayalaya Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Narayana Hrudayalaya - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    30 Apr 2025, 2:09PM Revised Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015-Penalty.
  • Narayana Hrudayalaya - General Updates

    29 Apr 2025, 2:43PM Narayana Hrudayalaya Ltd. has informed the Exchange about General Updates-Penalty
  • Narayana Hrudayalaya - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    29 Apr 2025, 2:36PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Penalty
  • Narayana Hrudayalaya has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    17 Apr 2025, 8:20PM As of March 2025, 63.85% is owned by Indian Promoters, 35.53% by Public and 0.62% by Non Promoters-Non Public. <p align=justify> Institutional holds 1
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Apr 2025, 5:09PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on April 16 2025
  • Narayana Hrudayalaya - Rumour Verification - Regulation 30(11)

    8 Apr 2025, 4:44PM Narayana Hrudayalaya Ltd. has informed the Exchange about Rumour Verification pursuant to Regulation 30 (11) of the Securities and Exchange Board of I
  • Narayana Hrudayalaya - Rumour verification - Regulation 30(11)

    8 Apr 2025, 4:39PM Rumour Verification pursuant to Regulation 30 (11) of the SEBI LODR Regulations, 2015 - Clarification on News.
  • Narayana Hrudayalaya - Agreements

    5 Apr 2025, 11:15AM Narayana Hrudayalaya Ltd. has informed the Exchange about Agreements- Intimation about execution of Operation and Management Agreement on April 05, 20
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    5 Apr 2025, 11:03AM Intimation about the execution of operation and management agreement on April 05, 2025.
  • Narayana Hrudayalaya - Updates

    28 Mar 2025, 9:55PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding 'Intimation regarding agreement between the wholly owned subsidiary of the Company- Nara
  • Narayana Hrudayalaya - Intimation Regarding Agreement Between The Wholly Owned Subsidiary Of The Company- Narayana Vaishno De

    28 Mar 2025, 9:40PM Pursuant to the Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that Narayana Vaishno Devi Specialty Hospitals Private Limited-w
  • Narayana Hrudayalaya - Trading Window-XBRL

    26 Mar 2025, 12:59PM NARAYANA HRUDAYALAYA LTD. has informed the Exchange about Closure of Trading Window
  • Narayana Hrudayalaya - Trading Window

    26 Mar 2025, 12:53PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Mar 2025, 3:39PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 21 2025
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Mar 2025, 3:48PM Intimation of schedule of investor meeting to be held on March 21, 2025\r\n
  • Narayana Hrudayalaya - General Updates

    8 Mar 2025, 2:33PM Narayana Hrudayalaya Ltd. has informed the Exchange about Intimation regarding Execution of Joint Venture Agreement by Health City Cayman IslandsLtd.
  • Narayana Hrudayalaya - Regulation 30_Intimation Regarding The Execution Of Joint Venture Agreement By Health City Cayman Isla

    8 Mar 2025, 2:40PM Intimation regarding the execution of the Joint Venture Agreement by Health City Cayman Islands Ltd., a wholly owned subsidiary of the company with 20
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Mar 2025, 2:25PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 19, 2025
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    7 Mar 2025, 2:20PM Intimation of schedule of investor meeting to be held on March 19 2025
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Feb 2025, 3:54PM Intimation of schedule of investor meeting to be held on March 04, 2025\r\n
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Feb 2025, 3:50PM Intimation of schedule of investor meeting to be held on March 06, 2025\r\n
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Feb 2025, 3:42PM Intimation of schedule of investor meeting to be held on March 07, 2025\r\n
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Feb 2025, 3:15PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 07 2025
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Feb 2025, 3:11PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 06, 2025
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Feb 2025, 3:07PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 04, 2025.
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Feb 2025, 5:07PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 07 2025
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Feb 2025, 5:03PM Narayana Hrudayalaya Ltd. has informed the Exchange about Transcript of the Earnings Call of the Company held on Tuesday, February 18, 2025
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    24 Feb 2025, 5:19PM Intimation of schedule of investor meeting to be held on March 07, 2025\r\n
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    24 Feb 2025, 5:13PM Transcript of the earning calls of the company held on Tuesday, February 18, 2025- Q3
  • Narayana Hrudayalaya - Capacity addition

    20 Feb 2025, 5:17PM Narayana Hrudayalaya Ltd. has informed the Exchange about Capacity addition-Foundation Stone laying ceremony for a 1100-bed new hospital project in Ko
  • Narayana Hrudayalaya - Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligat

    20 Feb 2025, 5:11PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Foundation Stone laying ceremony
  • Narayana Hrudayalaya - Rumour verification - Regulation 30(11)

    18 Feb 2025, 8:07PM Disclosure under Regulation 30(11) of SEBI LODR 2015
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Allotment

    18 Feb 2025, 8:03PM Intimation under Regulation 30 of SEBI LODR 2015- Allotment of non-convertible Debentures on private placement basis
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    18 Feb 2025, 7:58PM Audio recording of the earning calls scheduled today i.e. February 18, 2025 for the quarter ended December 31 2024\r\n
  • Narayana Hrudayalaya - Alteration Of Capital and Fund Raising-XBRL

    18 Feb 2025, 7:00PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding Allotment of Securities
  • Narayana Hrudayalaya - Rumour Verification - Regulation 30(11)

    18 Feb 2025, 6:55PM Narayana Hrudayalaya Ltd. has informed the Exchange about Rumour Verification - Regulation 30(11)
  • Narayana Hrudayalaya - Allotment of Securities

    18 Feb 2025, 6:37PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding allotment of 50000 securities at its borrowing committee meeting held on February 17, 20
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Feb 2025, 6:18PM Narayana Hrudayalaya Ltd. has informed the Exchange about Link of Recording of the earning call scheduled today i.e. February 18, 2025 for the quarter
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Feb 2025, 4:26PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet of investors to be held on March 03, 2025
  • Narayana Hrudayalaya - Copy of Newspaper Publication

    17 Feb 2025, 4:22PM Narayana Hrudayalaya Ltd. has informed the Exchange about Copy of Newspaper Publication of the unaudited (Standalone and Consolidated) Financial Resul
  • Narayana Hrudayalaya - Integrated Filing- Financial

    17 Feb 2025, 12:29PM Integrated Filing for the quarter ended December 31, 2024
  • Narayana Hrudayalaya - Integrated Filing- Financial

    17 Feb 2025, 12:22PM Integrated Filing - Financial
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    17 Feb 2025, 4:35PM Intimation of schedule of investor meeting to be held on March 03, 2025\r\n
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    15 Feb 2025, 6:10PM Intimation of Company's participation in the Investor's conference scheduled to be held on February 19, 2025\r\n
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    15 Feb 2025, 5:49PM Narayana Hrudayalaya Ltd. has informed the Exchange about Intimation of Company''s participation in the Investor's conference scheduled to be held on
  • Narayana Hrudayalaya - Acquisition-XBRL

    15 Feb 2025, 2:12PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding Acquisition
  • Narayana Hrudayalaya - Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The Company

    14 Feb 2025, 7:36PM Intimation of Acquisition of shares by Health City Cayman Islands Ltd. (HCCI), a wholly owned overseas subsidiary in a company in Bahamas.
  • Narayana Hrudayalaya - General Updates

    14 Feb 2025, 7:17PM Narayana Hrudayalaya Ltd. has informed the Exchange about the acquisition of shares by a wholly-owned overseas subsidiary in a Company in Bahamas
  • Narayana Hrudayalaya - General Updates

    14 Feb 2025, 7:08PM Narayana Hrudayalaya Ltd. has informed the Exchange about Integrated Filing for the quarter ended December 31, 2024
  • Narayana Hrudayalaya - Integrated Filing (Financial)

    14 Feb 2025, 7:05PM Integrated filing for the unaudited Standalone and Consolidated financial results for the quarter and nine months ended December 31,2024.
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 Feb 2025, 6:57PM Investors Presentation for the quarter ended December 31, 2024
  • Narayana Hrudayalaya - Press Release

    14 Feb 2025, 6:53PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding a press release dated February 14, 2025, titled ""Press Release for the Quarter ended De
  • Narayana Hrudayalaya Q3 net profit up 0.71% at Rs 79.22 cr

    14 Feb 2025, 6:50PM The company reported standalone net profit of Rs 79.22 crore for the quarter ended December 31, 2024 as compared to Rs 78.66 crore in the same period
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    14 Feb 2025, 6:49PM Press release for the quarter ended December 31, 2024 and Call invite.
  • Narayana Hrudayalaya - General Updates

    14 Feb 2025, 6:46PM Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation for the quarter ended December 31, 2024
  • Narayana Hrudayalaya - Board Meeting Outcome for Outcome Of Board Meeting Held On February 14, 2025

    14 Feb 2025, 6:45PM Outcome of the Board meeting for approving the Unaudited Financial Results for the quarter and nine months ended December 31, 2024
  • Narayana Hrudayalaya - Outcome of Board Meeting

    14 Feb 2025, 6:40PM Narayana Hrudayalaya Ltd. has informed the Exchange regarding Board meeting held on February 14, 2025.
  • Narayana Hrudayalaya - Financial Result Updates

    14 Feb 2025, 6:39PM Narayana Hrudayalaya Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Narayana Hrudayalaya - Result_Unaudited Financial Result For The Quarter And Nine Month Ended December 31, 2024

    14 Feb 2025, 6:38PM Unaudited standalone and consolidated financial results for the quarter and nine month ended December 31, 2024
  • Narayana Hrudayalaya - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    7 Feb 2025, 3:02PM Intimation of Investors meeting for the Quarter ended December 31, 2024.
  • Narayana Hrudayalaya - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Feb 2025, 2:55PM Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of meet: Call invite for Quarter ended December 31, 2024 Unaudited Financial Result
  • Narayana Hrudayalaya - Board Meeting Intimation

    7 Feb 2025, 2:41PM NARAYANA HRUDAYALAYA LTD. has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the Unaudited Fin
  • Narayana Hrudayalaya - Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financi

    7 Feb 2025, 2:34PM Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider
  • Narayana Hrudayalaya - Agreements

    5 Feb 2025, 5:04PM Narayana Hrudayalaya Ltd. has informed the Exchange about Purchase of Land in Bengaluru
  • Narayana Hrudayalaya - Intimation Regarding Purchase Of Land At Bengaluru

    5 Feb 2025, 5:18PM Enclosed herewith Intimation regarding Purchase of Land at Bengaluru
  • Narayana Hrudayalaya

    21 Feb 2025 , 9:52AM Investing Rs 900 crore for a Kolkata hospital, adding 1,100 beds over a period of 3-10 years in phases. The first phase of 350 beds is expected to commence operation in FY28-29. Positive
  • Narayana Hrudayalaya

    29 Nov 2024 , 10:01AM As per media reports, the company is in talks to acquire controlling stake in Spire Healthcare Co is UK's largest private hospital player in terms of revenue-Mkt value at $1.12bn
  • Narayana Hrudayalaya

    23 Nov 2023 , 10:37AM The Company has participated in Bengal Global Business Summit held in Kolkata on Tuesday, 21st November 2023, wherein Dr. Devi Prasad Shetty, Chairman reiterated the Company’s intent to invest upto Rs. 1,000 crore in the State for setting up a super specialty hospital (Positive)
  • Narayana Hrydayalaya

    6 Jul 2023 , 11:13AM Narayana Hrudalaya has formed a wholly owned subsidiary called Samyat Healthcare Pvt Ltd. with an authorized and paid-up capital of Rs. 10 lakhs to carry out the distribution of medicines, implants, medical equipment, and consumables, articles, and assets used in hospitals by manufacturing it and also be able to offer services in the areas of healthcare supply chain, pharmacy, and such services. Positive read through for the stock.
  • Narayana Hrudalaya

    31 Mar 2023 , 3:00PM Narayana Hrudalaya has appointed Mr. Venkatesh Rao as the COO from 1st April 2023 in place of Mr. Viren Shetty who has been made the Executive Vice Chairman since 1st April 2022. Positive for the stock
  • Narayana Hrudalaya

    24 Mar 2023 , 2:59PM Narayana Hrudalaya has signed and entered into a business transfer agreement on 24th March 2023 to transfer its business of running and operating few clinics located in Bangalore and Hosur as a “going concern” on slump sale basis to NH Integrated Care Pvt Ltd., a wholly owned subsidiary of Narayana Hrudalaya for a cash consideration of Rs. 10 Cr.
  • Narayana Hrudalaya

    8 Mar 2023 , 12:45PM Narayana Hrudalaya’s credit rating was upgraded to AA from AA- while outlook has been revised from positive to stable by ICRA. Last time we discussed its rating change now we may discuss its rationale for the upgrade. The upgrade was driven by improvement in its financial profile, which is expected to sustain in the future as well.
  • Narayana Hrudayalaya

    6 Mar 2023 , 2:02PM ICRA has upgraded credit rating on Narayana Hrudalaya’s bank facilities to AA with a Stable outlook from ICRA AA- with a Stable outlook, before. Positive read through for the stock.

Key fundamentals

Evaluate the intrinsic value of Narayana Hrudayalaya Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 2761.425 2011.83 1607.332 1424.487 1544.011
Liabilities 2761.425 2011.83 1607.332 1424.487 1544.011
Equity 204.361 204.361 204.361 204.361 204.361
Gross Profit 595.697 473.776 256.578 -31.12 256.691
Net Profit 424.517 265.639 133.598 -78.673 67.743
Cash From Operating Activities 542.129 516.257 245.989 123.423 286.434
NPM(%) 12.99 8.97 5.53 -4.75 3.02
Revenue 3265.702 2961.415 2411.987 1653.929 2239.351
Expenses 2670.005 2487.639 2155.409 1685.049 1982.66
ROE(%) 13.24 8.28 4.16 -2.45 2.11

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
02 Aug 2024 4 40 0.23 1252.75
07 Jul 2023 2.5 25 0.23 773.15
22 Aug 2022 1 10 0.23 662.85
11 Mar 2020 1 10 0.23 344.35
01 Aug 2019 1 10 0.23 199.05

Peers

Other companies within the same industry or sector that are comparable to Narayana Hrudayalaya Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 825.75 -1.80 11.65 1003.73 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 81.22 -0.17 338.42 3657.45 14.01 0.62
Vaishali Pharma Ltd 13.47 -1.82 449.00 1885.19 2.76 0.00
Astec Lifesciences Ltd 685.90 -1.03 0.00 3448.66 -687.11 0.00

Company Info

The Company was incorporated as Narayana Hridayalaya Private Limited on July 19, 2000 at Bengaluru, Karnataka as a private limited company under the Companies Act, 1956. Pursuant to a special resolution passed by the Shareholders dated January 02, 2008, the Company was renamed as Narayana Hrudayalaya Private Limited on January 11, 2008, and a fresh certificate of incorporation was issued by the RoC. The change in the name of the Company from Narayana Hridayalaya Private Limited to Narayana Hrudayalaya Private Limited was undertaken to rectify the error in the spelling of the word 'Hrudayalaya'. the Company was then converted into a public limited company and accordingly the name of the Company was changed to Narayana Hrudayalaya Limited pursuant to a special resolution passed by the Shareholders at the AGM held on August 08, 2015. A fresh certificate of incorporation consequent upon conversion to public limited company was issued on August 29, 2015. The KIADB approved the conversion of the Company from a private company to a public company by its letter dated August 21, 2015. Major events and milestones of the Company : 2000 -Commenced operations from NICS in Bengaluru 2008 -The Company entered into an investment agreement with the investor Selling Shareholders for the purpose of subscription by the investor Selling Shareholders to 75,414 Equity Shares of 10 each of the Company (in the aggregate) for a purchase price of 53,040.55 (approximately) per share, including share premium of 53,030.55 (approximately) per share 2014 -Acquired AHDL -Acquired the Jubilant Kalpataru Hospital, Barasat, West Bengal -the Company entered into a securities subscription agreement with CDC Group and CDC IOL for subscription to the Equity Shares and OCDs aggregating to 3,000,061,460.20 2015 -Obtained JCI accreditation for HCCI's multispecialty hospital in Cayman Islands Awards and Accreditations : 2010 -India Healthcare award by CNBC & ICICI Lombard under the category - Specialty hospital - Cardiology 2011 -NICS received accreditation from the JCI -Outstanding contribution to the society through CSR programs award conferred by CSR Thought Leadership Conclave organised by Wockhardt Foundation 2012 -Narayana Multispeciality Hospital, Jaipur received accreditation from the JCI -Ranked 36th in the World's 50 Most Innovative Companies by Fast Company -Healthcare Excellence award for Addressing Industry Issues conferred by the Federation of Indian Chambers of Commerce and Industry -India Healthcare Excellence award conferred by Frost and Sullivan 2013 -India Healthcare Excellence award conferred by Frost and Sullivan -Financial Times Arcelor Mittal Boldness in Business awards under the category - CSR/Environment -Porter Prize for Industry Architectural Shift -Inc. India Innovation 100 award -Philanthropy award by Forbes India - Good Company award -"Narayana Hrudayalaya - Malla Reddy Hospital" received accreditation from the NABH 2014 -RTIICS received accreditation from the NABH -MSMC received accreditation from the NABH 2013-2014 -State Export Excellence award under the category - Overall Service Sector 2014 -Gold award conferred by Asian Hospital Management under the category 'Customer Service -ABP news Brand Excellence award under the category' Healthcare and Hospitals -Super Specialty Hospital of the year award conferred by Hero Cycles' India Health and Wellness awards 2014 -Mentioned in the Boston Consulting Group Local Dynamo List for Operational Excellence 2015 -Healthcare Leadership award under the categories - Social Cause, Healthcare and Social Care Support and CEO of the year -HCCI obtained accreditation from the JCI for its facility in Grand Cayman, the Cayman Islands -Public Health Champion award under the category - Innovation conferred by the WHO, India 2016 -Healthcare India Health & Wellness Awards for Health Brand of the Year. -CSR Award to NH Jaipur at the 2nd annual Elets Healthcare Summit Rajasthan. -6th ICICI Lombard & CNBC TV 18 India Healthcare awards, NICS awarded Best Single Specialty Hospital- Cardiology. -Price/Performance Value Leadership Award by Frost & Sullivan India. -Best Risk Management Framework & Systems Healthcare by the 3rd edition of the ICICI Lombard CNBC TV18 India Risk Management Award. 2017 Narayana Hrudayalaya Ltd. has informed that pertaining to order passed by Regional Director-Hyderabad approving the Scheme of Amalgamation under Section 233 of the Companies Act, 2013. 2018 -Narayana Hrudayalaya Hospitals Malaysia Sdn Bhd , was registered as a wholly owned subsidiary of Narayana Hrudayalaya Limited ('NHL') on 27 September 2011 to set up and operate cardiac facilities in Malaysia. However, NHL had decided to terminate the project at its initial stages in FY 2014-15 due to various changes in the regulatory framework of Malaysia which made the project unviable. In view of the above NHL had decided to wind-up the said subsidiary in Malaysia. The subsidiary had commenced the process of Members' Voluntary Winding-up in 2017 as per the extant provisions of the Malaysian company law. The liquidation of the subsidiary has been completed and as per the search report from Companies Commission of Malaysia dated 24th April 2018, the status of the subsidiary is confirmed as dissolved. In this regard, as per Circular Number CIR/CFD/CMD/4/2015 dated September 09, 2015 pertaining to continuous disclosure requirements for Listed Entities under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, 2019 -Narayana Hrudayalaya Ltd. has informed that regarding 'Discontinuation of Hospital Project in Kenya '. -Narayana Hrudayalaya Ltd. acquired a Wholly-owned subsidiary, 'Narayana Health North America LLC' in the United States of America 2021 -Narayana Hrudayalaya Ltd. has informed that regarding 'Merger of Narayana Cayman Holdings Limited, a wholly owned subsidiary of Narayana Hrudayalaya Limited with Health City . Cayman Islands Limited, step down subsidiary of the Company'. 2022 -Excellence in Cardiology, Iconic Multispeciality Hospital of Rajasthan and Excellence in Cardiac Surgery. -Best Multispeciality Hospital in Rajasthan at Rajasthan Healthcare Summit and Doctors's Award. -Excellence in Neuro Sciences at All India Critical Care Hospital Ranking Survey 2022. 2023 Narayana Hrudayalaya completes acquisition of ENT in Cayma. 2024 -Narayana Health Hospital has successfully performed Chhattisgarh's first total awake craniotomy using advanced neuro-monitoring technology to remove a brain tumor.

The Company was incorporated as Narayana Hridayalaya Private Limited on July 19, 2000 at Bengaluru, Karnataka as a private limited company under the Companies Act, 1956. Pursuant to a special resolution passed by the Shareholders dated January 02, 2008, the Company was renamed as Narayana Hrudayalaya Private Limited on January 11, 2008, and a fresh certificate of incorporation was issued by the RoC. The change in the name of the Company from Narayana Hridayalaya Private Limited to Narayana Hrudayalaya Private Limited was undertaken to rectify the error in the spelling of the word 'Hrudayalaya'. the Company was then converted into a public limited company and accordingly the name of the Company was changed to Narayana Hrudayalaya Limited pursuant to a special resolution passed by the Shareholders at the AGM held on August 08, 2015. A fresh certificate of incorporation consequent upon conversion to public limited company was issued on August 29, 2015. The KIADB approved the conversion of the Company from a private company to a public company by its letter dated August 21, 2015. Major events and milestones of the Company : 2000 -Commenced operations from NICS in Bengaluru 2008 -The Company entered into an investment agreement with the investor Selling Shareholders for the purpose of subscription by the investor Selling Shareholders to 75,414 Equity Shares of 10 each of the Company (in the aggregate) for a purchase price of 53,040.55 (approximately) per share, including share premium of 53,030.55 (approximately) per share 2014 -Acquired AHDL -Acquired the Jubilant Kalpataru Hospital, Barasat, West Bengal -the Company entered into a securities subscription agreement with CDC Group and CDC IOL for subscription to the Equity Shares and OCDs aggregating to 3,000,061,460.20 2015 -Obtained JCI accreditation for HCCI's multispecialty hospital in Cayman Islands Awards and Accreditations : 2010 -India Healthcare award by CNBC & ICICI Lombard under the category - Specialty hospital - Cardiology 2011 -NICS received accreditation from the JCI -Outstanding contribution to the society through CSR programs award conferred by CSR Thought Leadership Conclave organised by Wockhardt Foundation 2012 -Narayana Multispeciality Hospital, Jaipur received accreditation from the JCI -Ranked 36th in the World's 50 Most Innovative Companies by Fast Company -Healthcare Excellence award for Addressing Industry Issues conferred by the Federation of Indian Chambers of Commerce and Industry -India Healthcare Excellence award conferred by Frost and Sullivan 2013 -India Healthcare Excellence award conferred by Frost and Sullivan -Financial Times Arcelor Mittal Boldness in Business awards under the category - CSR/Environment -Porter Prize for Industry Architectural Shift -Inc. India Innovation 100 award -Philanthropy award by Forbes India - Good Company award -"Narayana Hrudayalaya - Malla Reddy Hospital" received accreditation from the NABH 2014 -RTIICS received accreditation from the NABH -MSMC received accreditation from the NABH 2013-2014 -State Export Excellence award under the category - Overall Service Sector 2014 -Gold award conferred by Asian Hospital Management under the category 'Customer Service -ABP news Brand Excellence award under the category' Healthcare and Hospitals -Super Specialty Hospital of the year award conferred by Hero Cycles' India Health and Wellness awards 2014 -Mentioned in the Boston Consulting Group Local Dynamo List for Operational Excellence 2015 -Healthcare Leadership award under the categories - Social Cause, Healthcare and Social Care Support and CEO of the year -HCCI obtained accreditation from the JCI for its facility in Grand Cayman, the Cayman Islands -Public Health Champion award under the category - Innovation conferred by the WHO, India 2016 -Healthcare India Health & Wellness Awards for Health Brand of the Year. -CSR Award to NH Jaipur at the 2nd annual Elets Healthcare Summit Rajasthan. -6th ICICI Lombard & CNBC TV 18 India Healthcare awards, NICS awarded Best Single Specialty Hospital- Cardiology. -Price/Performance Value Leadership Award by Frost & Sullivan India. -Best Risk Management Framework & Systems Healthcare by the 3rd edition of the ICICI Lombard CNBC TV18 India Risk Management Award. 2017 Narayana Hrudayalaya Ltd. has informed that pertaining to order passed by Regional Director-Hyderabad approving the Scheme of Amalgamation under Section 233 of the Companies Act, 2013. 2018 -Narayana Hrudayalaya Hospitals Malaysia Sdn Bhd , was registered as a wholly owned subsidiary of Narayana Hrudayalaya Limited ('NHL') on 27 September 2011 to set up and operate cardiac facilities in Malaysia. However, NHL had decided to terminate the project at its initial stages in FY 2014-15 due to various changes in the regulatory framework of Malaysia which made the project unviable. In view of the above NHL had decided to wind-up the said subsidiary in Malaysia. The subsidiary had commenced the process of Members' Voluntary Winding-up in 2017 as per the extant provisions of the Malaysian company law. The liquidation of the subsidiary has been completed and as per the search report from Companies Commission of Malaysia dated 24th April 2018, the status of the subsidiary is confirmed as dissolved. In this regard, as per Circular Number CIR/CFD/CMD/4/2015 dated September 09, 2015 pertaining to continuous disclosure requirements for Listed Entities under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, 2019 -Narayana Hrudayalaya Ltd. has informed that regarding 'Discontinuation of Hospital Project in Kenya '. -Narayana Hrudayalaya Ltd. acquired a Wholly-owned subsidiary, 'Narayana Health North America LLC' in the United States of America 2021 -Narayana Hrudayalaya Ltd. has informed that regarding 'Merger of Narayana Cayman Holdings Limited, a wholly owned subsidiary of Narayana Hrudayalaya Limited with Health City . Cayman Islands Limited, step down subsidiary of the Company'. 2022 -Excellence in Cardiology, Iconic Multispeciality Hospital of Rajasthan and Excellence in Cardiac Surgery. -Best Multispeciality Hospital in Rajasthan at Rajasthan Healthcare Summit and Doctors's Award. -Excellence in Neuro Sciences at All India Critical Care Hospital Ranking Survey 2022. 2023 Narayana Hrudayalaya completes acquisition of ENT in Cayma. 2024 -Narayana Health Hospital has successfully performed Chhattisgarh's first total awake craniotomy using advanced neuro-monitoring technology to remove a brain tumor.

Read More

Parent Organisation

Narayana Hrudayalaya Ltd.

Founded

19/07/2000

Managing Director

Dr.Devi Prasad Shetty

NSE Symbol

NHEQ

FAQ

The current price of Narayana Hrudayalaya Ltd is ₹ 1760.50.

The 52-week high for Narayana Hrudayalaya Ltd is ₹ 1800.00 and the 52-week low is ₹ 1744.60.

The market capitalization of Narayana Hrudayalaya Ltd is currently ₹ 35977.72. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Narayana Hrudayalaya Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Narayana Hrudayalaya Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Narayana Hrudayalaya Ltd shares.

The CEO of Narayana Hrudayalaya Ltd is Dr.Devi Prasad Shetty, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT